Biofrontera Inc.

US$0.83As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BFRIHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (60.53%)
Div yield —
ROE (988.35%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.96
PE TTM —
TSR TTM (24.73%)
Mkt cap US$12.30M
ROIC (55.91%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.00
20.87%
(31.27%)
Hold 2|11|9|8|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
(8.19%)
(3.12%)
(0.79%)
8.15%
Revenue$M
0.868
0.870
0.879
0.884
8.47%
9.89%
8.23%
3.48%
Peers (US$12.30M)
Cap (US$)
PE
12.25M
4.268x
Capital
TTM
5Y
10Y
Leveragex
1.132
0.032
0.026
EBIT/Intx
0.918
0.226
0.233
Own earn%
(43.78)
(68.31)
(84.69)
Sh yield%
46.74
28.08
27.27
Owners
Insiders/Inst%
9.81
40.54
Short interest%
1.10
SBC / revenue%
1.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
16–23
$1 testx
—
Incr. ROIC%
15